A Prospective Study on the Treatment of cLM Based on ICG Imaging

Status Recruiting

Clinical Trial Summary

The goal of this prospective randomized controlled study is to explore the role of indocyanine green-fluorescence imaging in management of cystic lymphatic malformation.. To clarify the application value of indocyanine green-fluorescence imaging in both diagnosis and treatment of cystic lymphatic malformation (cLM) in children, is helpful for exploring pathogenesis of cLM, and providing a clearer scientific basis for subsequent surgical intervention. It also provides alternative for the future diagnosis and treatment of cLM. Participants will receive indocyanine green-fluorescence imaging before operation, while the patients in control group will receive traditional operation. Researchers will compare difference in curative effect between two groups.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06275022
Study type	Interventional
Source	Nanjing Children's Hospital
Contact	Tao Han, Dr.
Phone	+86 186 5190 3495
Email	dr.hantao@njmu.edu.cn
Status	Recruiting
Phase	N/A
Start date	January 1, 2023
Completion date	June 30, 2026

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT04994002` - A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations	Phase 1
Recruiting	`NCT05871970` - Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age	Phase 2
Terminated	`NCT04409145` - First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations	Phase 1/Phase 2
Recruiting	`NCT06437158` - Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients	Phase 2
Recruiting	`NCT03972592` - Topical Sirolimus in Cutaneous Lymphatic Malformations	Phase 2
Recruiting	`NCT03243019` - Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations	Phase 2
Recruiting	`NCT02399527` - Lymphatic Anomalies Registry for the Assessment of Outcome Data
Completed	`NCT06257719` - Clinical Characteristics of Lymphatic Malformations
Recruiting	`NCT04861064` - Weekly Sirolimus Therapy	Phase 2
Recruiting	`NCT05563831` - National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Not yet recruiting	`NCT05983159` - A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations	Phase 2
Completed	`NCT04836884` - Vascular Anomaly Pathology and Genomics Biopsy Study	N/A